Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Non-pharmacological educational and self-management interventions for people with chronic headache: the CHESS research programme including a RCT›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

Non-pharmacological educational and self-management interventions for people with chronic headache: the CHESS research programme including a RCT · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 11 min read

  1. Institute for Health Metrics and Evaluation. Global Burden of Disease Compare. 2017. https://vizhub.healthdata.org/gbd-compare/ (accessed March 2020).
  2. Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry 2006;77:385–7. 10.1136/jnnp.2005.07322116484650
  3. Kernick D, Stapley S and Hamilton W. GPs’ classification of headache: is primary headache underdiagnosed? Br J Gen Pract 2008;58:102–4. 10.3399/bjgp08X26407218307854
  4. Davies PTG, Lane RJM, Astbury T, Fontebasso M, Murphy J, Matharu M. The long and winding road: the journey taken by headache sufferers in search of help. Prim Health Care Res Dev 2019;20:e4. 10.1017/S146342361800032429848391
  5. National Institute for Health and Care Excellence (NICE). Headaches in Over 12s: Diagnosis and Management. Clinical Guideline [CG150]. London: NICE; 2012.
  6. Tassorelli C, Diener HC, Dodick DW, Silberstein SD, Lipton RB, Ashina M, et al. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. Cephalalgia 2018;38:815–32. 10.1177/033310241875828329504482
  7. Tfelt-Hansen P, Pascual J, Ramadan N, Dahlöf C, D’Amico D, Diener HC, et al. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia 2012;32:6–38. 10.1177/033310241141790122384463
  8. Henning V, Katsarava Z, Obermann M, Moebus S, Schramm S. Remission of chronic headache: rates, potential predictors and the role of medication, follow-up results of the German Headache Consortium (GHC) Study. Cephalalgia 2018;38:551–60. 10.1177/033310241769918028944686
  9. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808. 10.1177/033310241348565823771276
  10. Kristoffersen ES, Lundqvist C, Russell MB. Illness perception in people with primary and secondary chronic headache in the general population. J Psychosom Res 2019;116:83–92. 10.1016/j.jpsychores.2018.12.00130654999
  11. Westergaard ML, Lau CJ, Allesøe K, Gjendal ST, Jensen RH. Monitoring chronic headache and medication-overuse headache prevalence in Denmark. Cephalalgia 2020;40:6–18. 10.1177/033310241987690931522547
  12. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain 2015;156:1003–7. 10.1097/j.pain.000000000000016025844555
  13. Serrano D, Lipton RB, Scher AI, Reed ML, Stewart WBF, Adams AM, Buse DC. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. J Headache Pain 2017;18:101. 10.1186/s10194-017-0787-128980171
  14. White K, Potter R, Patel S, Nichols VP, Haywood KL, Hee SW, et al. Chronic Headache Education and Self-management Study (CHESS) – a mixed method feasibility study to inform the design of a randomised controlled trial. BMC Med Res Methodol 2019;19:30. 10.1186/s12874-019-0672-530744571
  15. Potter R, Probyn K, Bernstein C, Pincus T, Underwood M, Matharu M. Diagnostic and classification tools for chronic headache disorders: a systematic review. Cephalalgia 2019;39:761–84. 10.1177/033310241880686430335472
  16. Potter R, Hee SW, Griffiths F, Dodd K, Hoverd E, Underwood M, Matharu M. Development and validation of a telephone classification interview for common chronic headache disorders. J Headache Pain 2019;20:2. 10.1186/s10194-018-0954-z30621592
  17. National Migraine Centre. National Migraine Centre. URL: www.nationalmigrainecentre.org.uk/ (accessed June 2022).
  18. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol 1993;46:423–9. 10.1016/0895-4356(93)90018-v8501467
  19. Patel S, Potter R, Matharu M, Carnes D, Taylor SJC, Nichols V, et al. Development of an education and self-management intervention for chronic headache – CHESS trial (Chronic Headache Education and Self-management Study). J Headache Pain 2019;20:28. 10.1186/s10194-019-0980-530885120
  20. Nichols VP, Ellard DR, Griffiths FE, Kamal A, Underwood M, Taylor SJC, CHESS team. The lived experience of chronic headache: a systematic review and synthesis of the qualitative literature. BMJ Open 2017;7:e019929. 10.1136/bmjopen-2017-019929
  21. Probyn K, Bowers H, Caldwell F, Mistry D, Underwood M, Matharu M, Pincus T, CHESS Team. Prognostic factors for chronic headache: a systematic review. Neurology 2017;89:291–301. 10.1212/WNL.000000000000411228615422
  22. Probyn K, Bowers H, Mistry D, Caldwell F, Underwood M, Patel S, et al. Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components. BMJ Open 2017;7:e016670. 10.1136/bmjopen-2017-016670
  23. Mallen CD, Peat G, Thomas E, Dunn KM, Croft PR. Prognostic factors for musculoskeletal pain in primary care: a systematic review. Br J Gen Pract 2007;57:655–61.17688762
  24. Artus M, Campbell P, Mallen CD, Dunn KM, van der Windt DA. Generic prognostic factors for musculoskeletal pain in primary care: a systematic review. BMJ Open 2017;7:e012901. 10.1136/bmjopen-2016-012901
  25. Taylor SJ, Carnes D, Homer K, Kahan BC, Hounsome N, Eldridge S, et al. Novel three-day, community-based, nonpharmacological group intervention for chronic musculoskeletal pain (COPERS): a randomised clinical trial. PLOS Med 2016;13:e1002040. 10.1371/journal.pmed.100204027299859
  26. Haywood KL, Mars TS, Potter R, Patel S, Matharu M, Underwood M. Assessing the impact of headaches and the outcomes of treatment: a systematic review of patient-reported outcome measures (PROMs). Cephalalgia 2018;38:1374–86. 10.1177/033310241773134828920448
  27. Haywood KL, Achana F, Nichols V, Pearce G, Box B, Muldoon L, et al. Measuring health-related quality of life in chronic headache: a comparative evaluation of the Chronic Headache Quality of Life Questionnaire and Headache Impact Test (HIT-6). Cephalalgia 2021;41:1100–23. 10.1177/0333102421100604533942667
  28. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737–45. 10.1016/j.jclinepi.2010.02.00620494804
  29. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2012;21:651–7. 10.1007/s11136-011-9960-121732199
  30. Streiner DL, Norman GR, Cairney J. Health Measurement Scales: A Practical Guide to their Development and Use. 5th edn. Oxford: Oxford University Press; 2015. 10.1093/med/9780199685219.001.0001
  31. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in Medicine: A Practical Guide. Cambridge: Cambridge University Press; 2011. 10.1017/CBO9780511996214
  32. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34–42. 10.1016/j.jclinepi.2006.03.01217161752
  33. Kosinski M, Bayliss MS, Bjorner JB, Ware JE, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12:963–74. 10.1023/a:102611933119314651415
  34. Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ, Jhingran P. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache 2000;40:204–15. 10.1046/j.1526-4610.2000.00030.x10759923
  35. Revicki DA, Kimel M, Beusterien K, Kwong JW, Varner JA, Ames MH, et al. Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment. Headache 2006;46:240–52. 10.1111/j.1526-4610.2006.00289.x16492233
  36. Brédart A, Marrel A, Abetz-Webb L, Lasch K, Acquadro C. Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes 2014;12:15. 10.1186/1477-7525-12-1524499454
  37. Christodoulou C, Junghaenel DU, DeWalt DA, Rothrock N, Stone AA. Cognitive interviewing in the evaluation of fatigue items: results from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res 2008;17:1239–46. 10.1007/s11136-008-9402-x18850327
  38. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Content validity – establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2 – assessing respondent understanding. Value Health 2011;14:978–88. 10.1016/j.jval.2011.06.01322152166
  39. Haywood K, Potter R, Froud R, Pearce G, Box B, Muldoon L, et al. Core outcome set for preventive intervention trials in chronic and episodic migraine (COSMIG): an international, consensus-derived and multistakeholder initiative. BMJ Open 2021;11:e043242. 10.1136/bmjopen-2020-043242
  40. Khan K, Mistry H, Matharu M, Norman C, Petrou S, Stewart K, et al. Mapping between headache specific and generic preference-based health-related quality of life measures. BMC Med Res Methodol 2022;22:277.36289468
  41. Hareendran A, Skalicky A, Mannix S, Lavoie S, Desai P, Bayliss M, et al. Development of a new tool for evaluating the benefit of preventive treatments for migraine on functional outcomes – the Migraine Functional Impact Questionnaire (MFIQ). Headache 2018;58:1612–28. 10.1111/head.1342030374958
  42. Vivekanantham A, Edwin C, Pincus T, Matharu M, Parsons H, Underwood M. The association between headache and low back pain: a systematic review. J Headache Pain 2019;20:82. 10.1186/s10194-019-1031-y31307372
  43. Patel S, Achana F, Carnes D, Eldridge S, Ellard DR, Griffiths F, et al. Usual care and a self-management support programme versus usual care and a relaxation programme for people living with chronic headache disorders: a randomised controlled trial protocol (CHESS). BMJ Open 2020;10:e033520. 10.1136/bmjopen-2019-033520
  44. Underwood M, Achana F, Carnes D, Eldridge S, Ellard DR, Griffiths F, et al. Supportive Self-Management Program for People With Chronic Headaches and Migraine: A Randomized Controlled Trial and Economic Evaluation. Neurology 2023;100(13):e1339–52. 10.1212/WNL.000000000020151836526428
  45. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. 10.1007/s11136-011-9903-x21479777
  46. Jenkinson C, Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy 1997;2:14–8. 10.1177/13558196970020010510180648
  47. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70. 10.1111/j.1600-0447.1983.tb09716.x6880820
  48. Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain 2007;11:153–63.16446108
  49. Osborne RH, Elsworth GR, Whitfield K. The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Educ Couns 2007;66:192–201. 10.1016/j.pec.2006.12.00217320338
  50. Parsons S, Carnes D, Pincus T, Foster N, Breen A, Vogel S, Underwood M. Measuring troublesomeness of chronic pain by location. BMC Musculoskelet Disord 2006;7:34. 10.1186/1471-2474-7-3416597329
  51. Moerbeek M, Wong WK. Sample size formulae for trials comparing group and individual treatments in a multilevel model. Stat Med 2008;27:2850–64. 10.1002/sim.311517960589
  52. Taylor SJC, Carnes D, Homer K, Pincus T, Kahan BC, Hounsome N, et al. Improving the self-management of chronic pain: COping with persistent Pain, Effectiveness Research in Self-management (COPERS). Programme Grants Appl Res 2016;4(14). 10.3310/pgfar04140
  53. Cousins S, Ridsdale L, Goldstein LH, Noble AJ, Moorey S, Seed P. A pilot study of cognitive behavioural therapy and relaxation for migraine headache: a randomised controlled trial. J Neurol 2015;262:2764–72. 10.1007/s00415-015-7916-z26477023
  54. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. 10.1136/bmj.c33220332509
  55. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess 2001;5(33). 10.3310/hta5330
  56. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. PMG9. 2013. URL: www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781 (accessed June 2022).
  57. Curtis L, Burns A. Unit Costs of Health and Social Care 2019. Canterbury: PSSRU, University of Kent; 2019. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2019/ (accessed March 2021).
  58. NHS Business Services Authority. Prescription Cost Analysis – England 2019. URL: www.nhsbsa.nhs.uk/statistical-collections/prescription-cost-analysis-england/prescription-cost-analysis-england-2019 (accessed 23 June 2022).
  59. National Institute for Health and Care Excellence. British National Formulary. URL: https://bnf.nice.org.uk/ (accessed March 2021).
  60. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.00822867780
  61. Hernández-Alava M, Pudney S. Eq5Dmap: a command for mapping between EQ-5D-3L and EQ-5D-5L. Stata J 2018;18:395–415. 10.1177/1536867X1801800207
  62. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736–41. 10.1136/bmj.316.7133.7369529408
  63. National Institute for Health and Care Excellence. Position Statement on Use of the EQ-5D-5L Value Set for England (Updated October 2019). URL: www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l (accessed 28 September 2017).
  64. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42:851–9. 10.1097/01.mlr.0000135827.18610.0d15319610
  65. van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. J Stat Soft 2011;45:67. 10.18637/jss.v045.i03
  66. Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics 2014;32:1157–70. 10.1007/s40273-014-0193-325069632
  67. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons; 2004.
  68. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. 2nd ed. Oxford: Oxford University Press; 2014. 10.1093/med/9780199685028.001.0001
  69. Nichols VP, Ellard DR, Griffiths FE, Underwood M, Taylor SJC, Patel S, CHESS team. The CHESS trial: protocol for the process evaluation of a randomised trial of an education and self-management intervention for people with chronic headache. Trials 2019;20:323. 10.1186/s13063-019-3372-x31164158
  70. Ellard David R, Nichols Vivien P, Griffiths Frances E, Underwood Martin, Taylor Stephanie JC, CHESS team. Chronic Headache Education and Self-Management Study (CHESS): a process evaluation. BMC Neurol 2023;23(1):8. 10.1186/s12883-022-02792-136609224
  71. Nichols V, Pearce G, Ellard DR, Evans S, Haywood K, Norman C, et al. Patient and public involvement in a UK National Institute for Health Research Programme Grant for Applied Research: experiences from the Chronic Headache Education and Self-management Study (CHESS). Prim Health Care Res Dev 2021;22:e72. 10.1017/S146342362100067034796815
  72. National Institute for Health and Care Research. UK Standards for Public Involvement. URL: https://sites.google.com/nihr.ac.uk/pi-standards/home (accessed June 2022).
  73. Locock L, Boylan AM, Snow R, Staniszewska S. The power of symbolic capital in patient and public involvement in health research. Health Expect 2017;20:836–44. 10.1111/hex.1251927885770
  74. Toye F, Seers K, Hannink E, Barker K. A mega-ethnography of eleven qualitative evidence syntheses exploring the experience of living with chronic non-malignant pain. BMC Med Res Methodol 2017;17:116. 10.1186/s12874-017-0392-728764666
  75. Sharpe L, Dudeney J, Williams ACC, Nicholas M, McPhee I, Baillie A, et al. Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev 2019;7:CD012295. 10.1002/14651858.CD012295.pub231264211
  76. Martinez-Calderon J, Flores-Cortes M, Morales-Asencio JM, Fernandez-Sanchez M, Luque-Suarez A. Which interventions enhance pain self-efficacy in people with chronic musculoskeletal pain? A systematic review with meta-analysis of randomized controlled trials, including over 12 000 participants. J Orthop Sports Phys Ther 2020;50:418–30. 10.2519/jospt.2020.931932736497
  77. Kawata AK, Hareendran A, Shaffer S, Mannix S, Thach A, Desai P, et al. Evaluating the psychometric properties of the Migraine Functional Impact Questionnaire (MFIQ). Headache 2019;59:1253–69. 10.1111/head.1356931168803
  78. Ware JE Jr. SF-36 health survey update. Spine 2000;25:3130–9. 10.1097/00007632-200012150-0000811124729
  79. Smelt AF, Assendelft WJ, Terwee CB, Ferrari MD, Blom JW. What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients. Cephalalgia 2014;34:29–36. 10.1177/033310241349759923843470
  80. Lamb SE, Lall R, Hansen Z, Castelnuovo E, Withers EJ, Nichols V, et al. A multicentred randomised controlled trial of a primary care-based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial. Health Technol Assess 2010;14(41). 10.3310/hta14410
  81. Schwartz CE, Sajobi TT, Lix LM, Quaranto BR, Finkelstein JA. Changing values, changing outcomes: the influence of reprioritization response shift on outcome assessment after spine surgery. Qual Life Res 2013;22:2255–64. 10.1007/s11136-013-0377-x23519975
  82. Doane MJ, Gupta S, Vo P, Laflamme AK, Fang J. Associations between headache-free days and patient-reported outcomes among migraine patients: a cross-sectional analysis of survey data in Europe. Pain Ther 2019;8:203–16. 10.1007/s40122-019-0133-131350710
  83. Vo P, Fang J, Bilitou A, Laflamme AK, Gupta S. Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain 2018;19:82. 10.1186/s10194-018-0907-630203163
← List of supplementary material

Attribution. Martin Underwood; Felix Achana; Dawn Carnes; Sandra Eldridge; David R Ellard; Frances Griffiths et al. (2023). Non-pharmacological educational and self-management interventions for people with chronic headache: the CHESS research programme including a RCT. National Institute for Health and Care Research. Copyright © 2023 Underwood et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK593139. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support